Dexmedetomidine and Renal Transplants

Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Failure Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UC Davis Health System

Sacramento, California, 95817, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients greater than or equal to 18 years old that underwent renal transplant at UC Davis Medical Center -

Exclusion criteria

Patients that did not undergo renal transplants and patients less than 18 years old will be excluded from the study.

Treatment and study plan

Primary outcomes

Cr/GFR improvement, postoperative mortality/morbidity (within 30 days) and overall complications

Time frame: 5 years

Secondary outcomes

Graft failure, length of hospital stay (LOS), length of ICU stay, re-admission rate, infections, pulmonary complications.

Time frame: 5 years

Other outcomes

length of intubation time, and length of ventilation time

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2020
Study completion: 2020
First posted: Dec 24, 2013
Registry last updated: Jul 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed